Elekta AB (publ) (EKTAY)
OTCMKTS · Delayed Price · Currency is USD
5.02
0.00 (0.06%)
Aug 19, 2025, 1:55 PM EDT
Elekta AB Market Cap
Elekta AB has a market cap or net worth of $1.93 billion as of August 19, 2025. Its market cap has decreased by -19.40% in one year.
Market Cap
1.93B
Enterprise Value
2.42B
Revenue
1.86B
Ranking
n/a
PE Ratio
78.96
Stock Price
$5.02
Market Cap Chart
Since September 4, 1997, Elekta AB's market cap has increased from 191.46M to 1.93B, an increase of 909.74%. That is a compound annual growth rate of 8.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2025 | 1.93B | -8.61% |
| Dec 30, 2024 | 2.12B | -32.17% |
| Dec 29, 2023 | 3.12B | 35.48% |
| Dec 30, 2022 | 2.30B | -52.43% |
| Dec 30, 2021 | 4.84B | -6.05% |
| Dec 30, 2020 | 5.15B | 1.85% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.94M |
| Glass House Brands | 567.91M |
| American Oncology Network | 379.23M |
| Northwest Biotherapeutics | 363.17M |
| CytoDyn | 344.75M |